Group 1 - The core viewpoint of the news is that Shangmei Co., Ltd. reported strong financial performance for the first half of 2025, with significant revenue and profit growth, leading to a rise in stock price [1] - For the six months ending June 30, 2025, the company achieved a revenue of 4.108 billion yuan, a year-on-year increase of 17.29%, and a net profit attributable to shareholders of 524 million yuan, up 30.65% year-on-year [1] - The company plans to distribute an interim dividend of 0.5 yuan per share [1] Group 2 - The revenue from the Han Shu brand for the first half of 2025 was 3.344 billion yuan, an increase of 14.3% compared to 2.927 billion yuan in the first half of 2024, driven by brand upgrades and category expansion [1] - Han Shu maintained its leading position in the online beauty industry, ranking first in total gross merchandise value (GMV) on the Douyin platform and achieving the top spot in the "Douyin E-commerce Skincare Brand Overall Ranking H1" [1] - According to Haitong International, other brands under the company, such as Newpage, Yiyue, and Red Little Elephant, reported revenues of 397 million, 89 million, and 159 million yuan respectively, with Newpage showing a significant year-on-year growth of 146.5% [2]

消息面上，8月28日，上美股份发布截至2025年6月30日止六个月中期业绩，收入41.08亿元(人民币，下 同)，同比增加17.29%；股东应占溢利5.24亿元，同比增加30.65%；每股基本盈利1.32元；拟派发中期股 息每股0.5元。 公告称，2025年上半年，韩束应占集团的收入为33.44亿元，相比2024年上半年的29.27亿元增加 14.3%，主要是由于韩束品牌的整体升级和扩充品类带来的收入增长，及各渠道收入持续增长。2025年 上半年，韩束继续保持线上渠道美妆行业的领先地位。2025年上半年，韩束在抖音平台总成交额(GMV) 每月均位居美妆品牌第一，并取得"抖音电商护肤品牌总榜H1"第一的亮眼成绩。 智通财经APP获悉，上美股份(02145)涨超4%，截至发稿，涨3.54%，报93.6港元，成交额1.04亿港元。 海通国际指出，除韩束品牌外，25H1公司newpage一页/一叶子/红色小象分别实现营收3.97/0.89/1.59亿 元，分别同比+146.5%/-29.0%/-8.7%；营收占比分别为9.6%/2.2%/3.9%。其中newpage一页营收占比同比 +5pct，成为第二大收入贡献品牌 ...

Core Viewpoint - The report from CICC maintains the profit forecast for Shangmei Co., Ltd. (02145) for 2025-2026, with the current stock price corresponding to a P/E of 30/23x for those years, and raises the target price by 8% to HKD 106, indicating a potential upside of 17% [1] Group 1: Financial Performance - In 1H25, the company's revenue reached CNY 4.11 billion, a year-on-year increase of 17.3%, aligning with the upper limit of the previous earnings forecast [1] - The net profit for 1H25 was CNY 560 million, up 34.7% year-on-year, also exceeding the prior forecast range [1] - The attributable net profit was CNY 520 million, reflecting a year-on-year increase of 30.6%, meeting the expectations of the report [1] Group 2: Brand and Product Performance - The brand Han Shu achieved revenue of CNY 3.34 billion in 1H25, a year-on-year increase of 14%, with successful expansion across multiple product lines [2] - The brand Yipai saw a significant revenue increase of 146% year-on-year, reaching CNY 400 million, with strong sales of its star product [2] - The brand Hongse Xiaoxiang generated CNY 160 million in revenue, indicating initial success in its brand transformation [2] Group 3: Channel and Operational Efficiency - The company's gross margin improved by 1.7 percentage points to 75.5% in 1H25, while the sales expense ratio decreased by 0.7 percentage points to 56.9% [3] - The increase in the proportion of lower-cost external sales channels contributed to the optimization of the sales expense ratio [3] - The attributable net profit margin rose by 1.3 percentage points to 12.8% in 1H25, reflecting improved profitability [3] Group 4: Future Growth Strategy - The company continues to expand its brand matrix, having launched new brands in May and August, with positive initial results [4] - Plans for 2H25 include launching new brands targeting specific markets, such as a maternal and infant IP brand and a professional makeup brand [4] - The company aims to follow a "2+2+2" strategy over the next three years, focusing on skincare, hair care, and maternal-infant products to build a diverse brand portfolio [4]

Core Viewpoint - The report from CICC maintains the profit forecast for Shumei Co., Ltd. (02145) for 2025-2026, with the current stock price corresponding to a P/E ratio of 30/23x for those years, and raises the target price by 8% to HKD 106, indicating a potential upside of 17% [1] Group 1: Financial Performance - In the first half of 2025, the company's revenue reached RMB 4.11 billion, a year-on-year increase of 17.3%, exceeding the upper limit of the previous earnings forecast [1] - The net profit for 1H25 was RMB 560 million, up 34.7% year-on-year, also above the previous forecast range [1] - The attributable net profit was RMB 520 million, reflecting a year-on-year increase of 30.6%, aligning with the expectations of the report [1] Group 2: Brand and Product Performance - The Han Shu brand generated RMB 3.34 billion in revenue, a 14% year-on-year increase, with successful expansion across multiple product lines [2] - The Yi Ye brand saw a significant revenue increase of 146% year-on-year, reaching RMB 400 million, with strong sales of its star product [2] - The Hongse Xiaoxiang brand generated RMB 160 million, indicating initial success in brand transformation [2] Group 3: Channel and Operational Efficiency - The company's gross margin improved by 1.7 percentage points to 75.5% in 1H25, while the sales expense ratio decreased by 0.7 percentage points to 56.9% [3] - The online sales revenue was RMB 3.81 billion, a 20% year-on-year increase, accounting for 93% of total revenue, with significant growth driven by platforms like Tmall and JD [2] - The management and R&D expense ratios increased slightly, but overall profitability improved, with the attributable net profit margin rising by 1.3 percentage points to 12.8% [3] Group 4: Future Growth Strategy - The company continues to expand its brand matrix, having launched new brands in May and August, with positive initial results [4] - Plans for the second half of 2025 include launching new brands targeting specific markets, such as maternal and infant products and professional cosmetics [4] - The long-term strategy focuses on developing six major brands across three key sectors over the next three years, aiming for significant growth in the cosmetics industry [4]

Summary of Shangmei Co., Ltd. Conference Call Company Overview - Shangmei Co., Ltd. focuses on a multi-brand strategy across six major categories, including brands like Han Shu, New Page, and An Mi You, aiming to become a leader in the cosmetics industry empowered by research and development [1][3][6]. Financial Performance - In the first half of 2025, Shangmei achieved revenue of 4.108 billion RMB, a year-on-year increase of 17.3%, and a net profit of 1.056 billion RMB, up 34.7% year-on-year, with a net profit margin of 13.53% and a gross margin of 75.5% [1][11]. - Han Shu brand generated 3.3 billion RMB in revenue, growing 14% year-on-year, while New Page saw a remarkable 157% increase in revenue, exceeding 300 million RMB [1][17]. Strategic Goals - The company aims to reach a revenue target of 30 billion RMB by 2030, maintaining a gross margin of 36%-40% [2][6][33]. - The strategic plan includes a phased approach with Han Shu targeting 20 billion RMB in revenue, while other brands will cater to specific market segments [6][25]. Market Strategy - Shangmei emphasizes long-termism, multi-brand strategy, and continuous R&D investment to adapt to changing consumer behaviors and market competition [3][5]. - The company is focusing on enhancing product value and practicality, particularly in the mid-to-high-end maternal and infant market with New Page [5][6]. Brand Development - The core business (HE) includes Han Shu, while growth businesses (HR) cover functional skincare and personal care brands like An Mi You and Yi Ye Zi [4][5]. - New brands are being rapidly developed and are expected to achieve profitability quickly, with successful launches already reported [19][30]. Channel Management - The company has optimized its channel structure, with Douyin (TikTok) being a primary sales channel, accounting for 68% of total sales, and self-broadcasting increasing from 55% to 86% [16][22]. - Shangmei is exploring innovative offline retail strategies and enhancing user experience through partnerships with various retail environments [20][21]. Competitive Advantages - Shangmei maintains its competitive edge through innovative marketing strategies, strong R&D capabilities, and a flexible management structure that allows for rapid response to market changes [7][26][28]. - The company has established a robust supply chain and a collaborative internal culture that fosters agility and creativity [27][28]. Future Outlook - The company anticipates a growth rate of 25% for 2026 in both sales and profits, driven by platforms like Douyin and contributions from emerging brands [35]. - Shangmei is committed to international expansion, with plans to establish a presence in Southeast Asia and focus on local talent development [36]. Additional Insights - Shangmei's approach to talent management includes a decentralized decision-making process, allowing young teams to operate with autonomy once they achieve profitability [30][31]. - The company has set clear criteria for future acquisitions, focusing on achieving specific sales and profit milestones before pursuing larger-scale purchases [32]. This summary encapsulates the key points from the conference call, highlighting Shangmei's strategic direction, financial performance, and market positioning within the cosmetics industry.

Industry Overview - The beauty industry is witnessing significant developments, including financial reports from various companies and the successful registration of new raw materials like Ursolic Acid [1] - Major brands are launching new products and entering new markets, indicating a dynamic and evolving landscape [1] Company Performance - Up Beauty reported a record revenue of 4.108 billion yuan for the first half of 2025, a year-on-year increase of 17.3%, with a net profit of 556 million yuan, up 34.7% [2] - Giant Biological achieved a revenue of 3.113 billion yuan in the first half of 2025, reflecting a 22.5% year-on-year growth, with a net profit of 1.182 billion yuan, up 20.6% [21] - Huaxi Biological reported a revenue of 2.261 billion yuan, with net profit figures showing no growth, but signs of strategic adjustments beginning to take effect [22] - Marubi Biological's revenue for the first half of 2025 reached 1.769 billion yuan, a 30.83% increase year-on-year, with a net profit of 186 million yuan, up 5.21% [23] New Product Developments - Up Beauty is preparing to launch a new makeup brand called "Dan Cai" in collaboration with a renowned makeup artist [2] - COSMAX announced breakthroughs in anti-aging and whitening products, including a new NAD-based anti-aging cosmetic and a new whitening powder [3] - LV Cosmetics has begun global pre-sales, indicating a strong push into the market [15] Executive Changes - Proya appointed new executives, including Xue Xia as the board secretary and Guo Xiao as the Chief Marketing Officer, both bringing extensive experience in the consumer sector [4] - Givaudan announced a leadership change, with Gilles Andrier stepping down as CEO in March 2026, to be succeeded by Christian Stammkoetter [5] Market Trends - The beauty and skincare market saw sales of 235.23 billion yuan in the first half of 2025, a 10.1% year-on-year increase, with anti-aging products showing a significant growth of 30.3% [24] - The introduction of innovative products and strategic partnerships, such as COSMAX's collaboration with Korea University for climate-proof cosmetics, reflects the industry's adaptability to changing consumer needs [15]

线上增长势能仍强，线下新模式待启。1）线上渠道：25H1 营收38.09 亿元，同比+20.1%，占总营收 92.7%，其中线上自营收入34.21 亿元，同比+24.6%，受益于韩束在抖音渠道的头部优势，同时快手、 拼多多等平台布局成效显现；2）线下渠道：25H1 营收2.69 亿元，同比-10.6%，战略转型深化，未来线 下也将成为发力点，以新模式突破。 机构：申万宏源研究 研究员：王立平/王盼 投资要点： 业绩符合预期，盈利弹性显著释放。1）整体表现：25H1 实现营业收入41.08 亿元，同增17.3%；净利 润5.56 亿元，同增34.7%，逆势强劲增长；2）分红预案：每10 股派5 元，现金分红约1.99 亿元，分红 比例约38%。 盈利能力维持高位，研发投入加码技术壁垒。1）盈利水平：25H1 毛利率75.5%，同比-1pct，小幅下滑 但仍位于行业高位；净利率13.5%，同比+1.75pct；2）费用水平：销售费用率56.9%，同比-0.7pct；管 理费用率3.7%，同比+0.5pct；研发费用率2.5%，同比+0.3pct，期内新申请专利27 项，基础研究与应用 转化能力持续强化。 多品牌矩 ...

Core Viewpoint - The company's 1H25 performance aligns with previous forecasts, showing significant growth in revenue and net profit, indicating a strong operational trajectory and effective brand strategies [1][2]. Financial Performance - The company reported a revenue of 4.11 billion yuan for 1H25, a year-on-year increase of 17.3%, exceeding the upper limit of the previous forecast [1] - Net profit reached 560 million yuan, up 34.7% year-on-year, also above the forecast range [1] - The company's net profit attributable to shareholders was 520 million yuan, reflecting a year-on-year increase of 30.6% [1] Development Trends - The company successfully expanded multiple product lines, with the brand "韩束" generating 3.34 billion yuan in revenue, a 14% increase year-on-year [1] - The brand "一页" saw a remarkable revenue increase of 146% year-on-year, reaching 400 million yuan [1] - Online sales accounted for 93% of total revenue, with a 20% year-on-year increase, while offline sales decreased by 11% [1][2] Profitability and Efficiency - The gross margin for 1H25 was 75.5%, with a year-on-year decrease of 1.0 percentage points but an increase of 1.7 percentage points from the previous half [2] - The sales expense ratio decreased by 0.7 percentage points to 56.9%, attributed to a reduction in the proportion of sales through the main brand's Douyin platform [2] - The net profit margin attributable to shareholders increased by 1.3 percentage points to 12.8% [2] Brand Expansion Strategy - The company is expanding its brand matrix, having launched new brands in May and August, with plans for further launches in 2H25 [2] - The long-term strategy focuses on developing six major brands across three key sectors: skincare, hair care, and maternal and infant products [2] Profit Forecast and Valuation - The profit forecast for 2025-2026 remains unchanged, with the current stock price corresponding to a P/E ratio of 30x for 2025 and 23x for 2026 [3] - The target price has been raised by 8% to 106 HKD, reflecting a potential upside of 17% based on the company's growth prospects [3]

Core Viewpoint - The company reported a steady revenue growth in H1 2025, driven by its main brand Han Shu and the rapid growth of the sub-brand Yi Ye [1][2]. Revenue Performance - In H1 2025, the company achieved a revenue of 4.108 billion yuan, representing a year-on-year increase of 17.29% [1]. - Revenue breakdown by brand: - Han Shu: 3.344 billion yuan, up 14.27%, accounting for 81.40% of total revenue [1]. - Yi Ye: 397 million yuan, up 146.46%, accounting for 9.67% of total revenue [1]. - Hong Se Xiao Xiang: 159 million yuan, down 8.67%, accounting for 3.87% of total revenue [2]. - Yi Ye Zi: 89 million yuan, down 29.02%, accounting for 2.16% of total revenue [2]. Category Performance - Revenue by category: - Skincare: 3.424 billion yuan, up 10.15%, accounting for 83.35% of total revenue, mainly driven by Han Shu [2]. - Maternal and infant care: 557 million yuan, up 65.05%, accounting for 13.55% of total revenue, mainly driven by Yi Ye [2]. - Other categories: 127 million yuan, up 124.30%, accounting for 3.10% of total revenue [2]. Channel Performance - Revenue by channel: - Online channels: 3.809 billion yuan, up 20.09%, accounting for 92.71% of total revenue, with online self-operated sales at 3.421 billion yuan, up 24.62% [2]. - Offline channels: 269 million yuan, down 10.64%, accounting for 6.54% of total revenue [2]. - Other channels: 31 million yuan, up 1.33%, accounting for 0.74% of total revenue [2]. Profitability - The company maintained a stable gross margin of 75.52%, down 0.99 percentage points, and a net profit margin of 12.76%, up 1.30 percentage points [3]. - The increase in net profit margin is attributed to other income and gains reaching 179 million yuan, up 358% [3]. Investment Outlook - The company focuses on a multi-brand strategy, with Han Shu's brand strength expected to continue growing through category expansion and channel development [3]. - Revenue projections for 2025-2027 are 8.511 billion yuan, 10.412 billion yuan, and 12.541 billion yuan, with net profits of 1.054 billion yuan, 1.340 billion yuan, and 1.671 billion yuan respectively [3].

Core Viewpoint - The company reported strong performance for H1 2025, with revenue of 4.11 billion yuan, a year-on-year increase of 17.3%, and a net profit of 560 million yuan, up 34.7% year-on-year, falling within the upper range of previous forecasts [1][2]. Revenue Breakdown - The multi-brand matrix continues to grow, with online revenue increasing by 20.1% year-on-year in H1 2025. By brand, revenue for 韩束, Newpage 一页, 红色小象, 一叶子, and other brands were 3.34 billion, 400 million, 160 million, 90 million, and 120 million yuan respectively, with year-on-year changes of +14.3%, +146.5%, -8.7%, -29.0%, and +2.9% [1]. - By channel, online and offline revenues were 3.81 billion and 270 million yuan respectively, with year-on-year changes of +20.1% and -10.6% [1]. - By segment, skincare, maternal and infant care, and other categories generated revenues of 3.42 billion, 560 million, and 130 million yuan respectively, with year-on-year changes of +10.2%, +65.0%, and +124.3% [1]. Profitability Metrics - The net profit margin increased by 1.7 percentage points year-on-year to 13.5%. The gross margin for H1 2025 was 75.5%, down 1 percentage point year-on-year, while the expense ratio was 63.2%, up 0.03 percentage points [2]. Brand Performance - The main brand 韩束 showed steady growth, maintaining the top position in beauty brands on Douyin, with GMV growth of +15.5% on Douyin and +26.1% on Tmall. Star products like 红蛮腰 sold over 15 million units, and the X 肽 series generated over 200 million yuan in sales [2]. - The Newpage 一页 brand rapidly expanded, targeting skincare products for ages 0-18, with significant sales during the 618 shopping festival, achieving GMV growth of +190% on Douyin and +106% on Tmall [2]. Brand Portfolio Expansion - The company has a robust pipeline of brands across multiple segments, including a sensitive skin care brand in collaboration with 昆药集团, a high-end skincare brand 聚光白, and a high-end anti-aging brand TAZU. Additionally, it is preparing to launch IP co-branded products in maternal and infant care and new hair care and makeup brands [3]. Profit Forecast and Investment Rating - The company is expected to achieve net profits of 1.11 billion, 1.41 billion, and 1.76 billion yuan for 2025-2027, representing year-on-year growth of 42.3%, 26.5%, and 24.8% respectively. The latest closing price corresponds to PE ratios of 30, 24, and 19 times for the respective years, maintaining a "buy" rating [3].